{"id":118600,"date":"2022-04-20T10:40:02","date_gmt":"2022-04-20T10:40:02","guid":{"rendered":"https:\/\/www.lcalex.it\/?post_type=evento&#038;p=118600"},"modified":"2022-04-21T15:24:26","modified_gmt":"2022-04-21T15:24:26","slug":"the-nasdaq-ipo-path-for-italian-life-science-companies","status":"publish","type":"evento","link":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/","title":{"rendered":"The NASDAQ IPO Path for Italian Life Science Companies"},"content":{"rendered":"<p>On <strong>Thursday<\/strong>, <strong>5 May<\/strong> at <strong>5.30 PM<\/strong>, <strong>LCA <\/strong>&#8211; in collaboration with <strong>Goodwin<\/strong> &#8211; will host the webinar &#8220;The NASDAQ IPO Path for Italian Life Science Companies: Genenta Science&#8217;s Case Study&#8221;, which will involve Ettore Santucci (<a href=\"https:\/\/www.goodwinlaw.com\/\">Goodwin<\/a>), Pierluigi Paracchi (<a href=\"https:\/\/www.genenta.com\/\">Genenta<\/a>), Aparna Beeram (<a href=\"https:\/\/www.roth.com\/\">Roth Capital Partners<\/a>), Federica Draghi (<a href=\"https:\/\/www.genextra.it\/\">Genextra<\/a>) and Leonardo Vingiani (<a href=\"https:\/\/assobiotec.federchimica.it\/\">Federchimica Assobiotec<\/a>), together with Andrea Messuti (LCA).<\/p>\n<p>Starting from Genenta&#8217;s successful IPO on Nasdaq, the aim of the webinar is to provide an overview of the challenges and opportunities for companies that want to prepare for the listed market, with a focus on the Life Sciences world.<\/p>\n<p>What are the key attributes of a company to be suitable for a NASDAQ IPO, what critical features public market investors look for when evaluating the issuer&#8217;s potential as a successful listed company, and how the Italian ecosystem supports and sustains companies in their early stages to get prepared for the listed market: these are some of the topics that the speakers will point out during the event.<\/p>\n<p><em>The webinar will be held in <strong>English<\/strong> and it will last about 90 minutes, ending with a Q&amp;A session<\/em>.<\/p>\n<p>Participation is free of charge.<\/p>\n<p>Fill in the registration form here below to receive the access link!<\/p>\n","protected":false},"featured_media":118592,"template":"","categories":[3161],"industry":[],"desk":[],"tipologia":[],"persone":[2925],"practice":[2096],"your_legal_counsel":[],"class_list":["post-118600","evento","type-evento","status-publish","has-post-thumbnail","hentry","category-events-en","persone-messuti-andrea-en","practice-ma-private-equity-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The NASDAQ IPO Path for Italian Life Science Companies<\/title>\n<meta name=\"description\" content=\"On Thursday, 5 May at 5.30 PM, LCA \u2013 in collaboration with Goodwin \u2013 will host the webinar \u201cThe NASDAQ IPO Path for Italian Life Science Companies: Genenta Science\u2019s Case Study\u201d,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The NASDAQ IPO Path for Italian Life Science Companies\" \/>\n<meta property=\"og:description\" content=\"On Thursday, 5 May at 5.30 PM, LCA \u2013 in collaboration with Goodwin \u2013 will host the webinar \u201cThe NASDAQ IPO Path for Italian Life Science Companies: Genenta Science\u2019s Case Study\u201d,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"LCA Studio Legale\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-21T15:24:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lcalex.it\/wp-content\/uploads\/2022\/04\/Articoli-sito-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/\",\"url\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/\",\"name\":\"The NASDAQ IPO Path for Italian Life Science Companies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lcalex.it\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/Articoli-sito-2.jpg\",\"datePublished\":\"2022-04-20T10:40:02+00:00\",\"dateModified\":\"2022-04-21T15:24:26+00:00\",\"description\":\"On Thursday, 5 May at 5.30 PM, LCA \u2013 in collaboration with Goodwin \u2013 will host the webinar \u201cThe NASDAQ IPO Path for Italian Life Science Companies: Genenta Science\u2019s Case Study\u201d,\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.lcalex.it\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/Articoli-sito-2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.lcalex.it\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/Articoli-sito-2.jpg\",\"width\":800,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/the-nasdaq-ipo-path-for-italian-life-science-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The NASDAQ IPO Path for Italian Life Science Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/\",\"name\":\"LCA Studio Legale\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/#organization\",\"name\":\"LCA Studio Legale\",\"url\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.lcalex.it\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/LCA70-3.ico\",\"contentUrl\":\"https:\\\/\\\/www.lcalex.it\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/LCA70-3.ico\",\"width\":256,\"height\":256,\"caption\":\"LCA Studio Legale\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lcalex.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/lca-studio-legale\\\/\",\"https:\\\/\\\/www.instagram.com\\\/lcastudiolegale\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The NASDAQ IPO Path for Italian Life Science Companies","description":"On Thursday, 5 May at 5.30 PM, LCA \u2013 in collaboration with Goodwin \u2013 will host the webinar \u201cThe NASDAQ IPO Path for Italian Life Science Companies: Genenta Science\u2019s Case Study\u201d,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/","og_locale":"en_US","og_type":"article","og_title":"The NASDAQ IPO Path for Italian Life Science Companies","og_description":"On Thursday, 5 May at 5.30 PM, LCA \u2013 in collaboration with Goodwin \u2013 will host the webinar \u201cThe NASDAQ IPO Path for Italian Life Science Companies: Genenta Science\u2019s Case Study\u201d,","og_url":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/","og_site_name":"LCA Studio Legale","article_modified_time":"2022-04-21T15:24:26+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/www.lcalex.it\/wp-content\/uploads\/2022\/04\/Articoli-sito-2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/","url":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/","name":"The NASDAQ IPO Path for Italian Life Science Companies","isPartOf":{"@id":"https:\/\/www.lcalex.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/#primaryimage"},"image":{"@id":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lcalex.it\/wp-content\/uploads\/2022\/04\/Articoli-sito-2.jpg","datePublished":"2022-04-20T10:40:02+00:00","dateModified":"2022-04-21T15:24:26+00:00","description":"On Thursday, 5 May at 5.30 PM, LCA \u2013 in collaboration with Goodwin \u2013 will host the webinar \u201cThe NASDAQ IPO Path for Italian Life Science Companies: Genenta Science\u2019s Case Study\u201d,","breadcrumb":{"@id":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/#primaryimage","url":"https:\/\/www.lcalex.it\/wp-content\/uploads\/2022\/04\/Articoli-sito-2.jpg","contentUrl":"https:\/\/www.lcalex.it\/wp-content\/uploads\/2022\/04\/Articoli-sito-2.jpg","width":800,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.lcalex.it\/en\/the-nasdaq-ipo-path-for-italian-life-science-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lcalex.it\/en\/"},{"@type":"ListItem","position":2,"name":"The NASDAQ IPO Path for Italian Life Science Companies"}]},{"@type":"WebSite","@id":"https:\/\/www.lcalex.it\/en\/#website","url":"https:\/\/www.lcalex.it\/en\/","name":"LCA Studio Legale","description":"","publisher":{"@id":"https:\/\/www.lcalex.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lcalex.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.lcalex.it\/en\/#organization","name":"LCA Studio Legale","url":"https:\/\/www.lcalex.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lcalex.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.lcalex.it\/wp-content\/uploads\/2025\/03\/LCA70-3.ico","contentUrl":"https:\/\/www.lcalex.it\/wp-content\/uploads\/2025\/03\/LCA70-3.ico","width":256,"height":256,"caption":"LCA Studio Legale"},"image":{"@id":"https:\/\/www.lcalex.it\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/lca-studio-legale\/","https:\/\/www.instagram.com\/lcastudiolegale\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/evento_post\/118600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/evento_post"}],"about":[{"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/types\/evento"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/media\/118592"}],"wp:attachment":[{"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/media?parent=118600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/categories?post=118600"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/industry?post=118600"},{"taxonomy":"desk","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/desk?post=118600"},{"taxonomy":"tipologia","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/tipologia?post=118600"},{"taxonomy":"persone","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/persone?post=118600"},{"taxonomy":"practice","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/practice?post=118600"},{"taxonomy":"your_legal_counsel","embeddable":true,"href":"https:\/\/www.lcalex.it\/en\/wp-json\/wp\/v2\/your_legal_counsel?post=118600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}